Molecular Characterization of NS5A Resistance Associated Substitutions after Failure of Sofosbuvir/Daclatasvir Combination Therapy in Chronic Hepatitis C genotype 4a Infected Egy

Impact of gene polymorphism on Egyptian HCV patients under direct antiviral Drugs

Impact of direct-acting antiviral therapy in Egyptian patients with chronic hepatitis C and liver cirrhosis

Comparison between Different Lines of Antiviral Combination Therapies against Hepatitis C Virus Genotype 4 in Egyptian Patients

EVALUATION OF THE SAFETY AND RESISTANCE ASSOCIATED VARIANTS OF SOFOSBUVIR/DACLATASVIR AMONG EGYPTIAN PATIENTS WITH HEPATITIS C VIRUS: A PROSPECTIVE STUDY

The outcome of the sofosbuvir Based Therapy in the treatment of Hepatitis C Virus Genotype 4 in Egyptian patients

SAFETY AND EFFICACY OF DIRECTLY ACTING ANTIVIRAL DRUGS IN TREATMENT OF CHRONIC HCV EGYPTIAN PATIENTS

Efficacy and Safety of Daclatasvir and Sofosbuvir in Egyptian Patients with Chronic Hepatitis C Genotype 4 and Cirrhosis

Characterization of Drug –resistance Profiles to Directly Acting Agents in Hepatitis C virus Naive Patients

Genetic Variants in ITPA and TNFSF10A Are Associated with the Risk of HCV Infection Among Egyptian Populations